Physician profile
Jonathan S Dial
NPI 1366523292
$208.97
in general payments reported to CMS, 2019-2025
8 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $50.39 · 2024: $13.09 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $59.15 | 2025 | Farxiga, Airsupra |
| Alexion Pharmaceuticals, INC. | $26.65 | 2022 | |
| Exact Sciences Corporation | $26.61 | 2025 | The Cologuard Plus Collection Kit |
| Innocoll Pharmaceuticals Limited | $23.74 | 2022 | |
| Novo Nordisk INC | $21.53 | 2025 | Ozempic |
| Sanofi Pasteur INC. | $20.20 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.00 | 2025 | Caplyta |
| Medtronic, INC. | $13.09 | 2024 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dial listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.